Stony Brook University
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Established
- 1957-01-01
- Employees
- 251
- Market Cap
- -
- Website
- http://www.stonybrook.edu
Investigating the Impact of Mode of Administration on Item Response
Completed
- Conditions
- Chronic Obstructive Pulmonary DiseaseDepressionRheumatoid Arthritis
- First Posted Date
- 2008-11-02
- Last Posted Date
- 2013-06-06
- Lead Sponsor
- Stony Brook University
- Target Recruit Count
- 800
- Registration Number
- NCT00783991
- Locations
- 🇺🇸
Polimetrix, Palo Alto, California, United States
🇺🇸Rheumatology Associates of Long Island, Smithtown, New York, United States
Effectiveness of a Training Program in Improving Coping Skills in People With Arthritis Pain
Phase 2
Completed
- Conditions
- Osteoarthritis
- Interventions
- Other: Usual careBehavioral: Coping skills training (CST) for chronic pain
- First Posted Date
- 2008-03-14
- Last Posted Date
- 2013-09-27
- Lead Sponsor
- Stony Brook University
- Target Recruit Count
- 257
- Registration Number
- NCT00636454
- Locations
- 🇺🇸
Rheumatology Associates of Long Island, Smithtown and Port Jefferson, New York, United States
🇺🇸Piedmont Primary Care, Danville, Virginia, United States
🇺🇸Stony Brook Primary Care, Setauket, New York, United States
IGF-1 Therapy in Patients With Cystic Fibrosis
Phase 1
Terminated
- Conditions
- Cystic Fibrosis
- Interventions
- Drug: recombinant human IGF-1Drug: Placebo
- First Posted Date
- 2007-12-03
- Last Posted Date
- 2013-01-28
- Lead Sponsor
- Stony Brook University
- Target Recruit Count
- 15
- Registration Number
- NCT00566241
- Locations
- 🇺🇸
State University of New York, Stony Brook, New York, United States
Lidocaine Patches Prior to Intravenous Insertion
Phase 2
Completed
- Conditions
- Need for Intravenous Catheter
- Interventions
- Device: Lidocaine tetracaineDevice: Placebo
- First Posted Date
- 2007-11-02
- Last Posted Date
- 2012-10-22
- Lead Sponsor
- Stony Brook University
- Target Recruit Count
- 45
- Registration Number
- NCT00552695
- Locations
- 🇺🇸
Stony Brook University Hospital, Stony Brook, New York, United States
Effect of Pioglitazone on the Course of New Onset Type 1 Diabetes Mellitus
Phase 1
Completed
- Conditions
- Type 1 Diabetes Mellitus
- Interventions
- Drug: Placebo control
- First Posted Date
- 2007-10-17
- Last Posted Date
- 2012-05-31
- Lead Sponsor
- Stony Brook University
- Target Recruit Count
- 15
- Registration Number
- NCT00545857
- Locations
- 🇺🇸
Thomas A. Wilson, MD, Stony Brook, New York, United States
Comparison of Suturing and Packing of Drained Abscesses
Phase 2
Completed
- Conditions
- Cutanoeus Abscesses
- Interventions
- Other: PRIMARY CLOSREOther: SECONDARY CLOSUREOther: SPONTANEOUS HALING
- First Posted Date
- 2007-04-24
- Last Posted Date
- 2012-10-22
- Lead Sponsor
- Stony Brook University
- Target Recruit Count
- 100
- Registration Number
- NCT00465049
- Locations
- 🇺🇸
Stony Brook University Hospital, Stony Brook, New York, United States
Methylphenidate for Treating Children With ADHD and Tourette Syndrome
Not Applicable
Completed
- Conditions
- Attention Deficit Disorder With HyperactivityTourette Syndrome
- First Posted Date
- 2007-03-01
- Last Posted Date
- 2013-10-31
- Lead Sponsor
- Stony Brook University
- Target Recruit Count
- 71
- Registration Number
- NCT00441649
Aerosolized Antibiotics and Respiratory Tract Infection in Patients on Mechanical Ventilation
Phase 2
Completed
- Conditions
- Ventilator Associated PneumoniaRespiratory InfectionTracheobronchitis
- First Posted Date
- 2006-11-07
- Last Posted Date
- 2006-11-07
- Lead Sponsor
- Stony Brook University
- Target Recruit Count
- 80
- Registration Number
- NCT00396578
- Locations
- 🇺🇸
University Hospital Medical Center, Stony Brook, New York, United States
Nitric Oxide-Releasing Acetylsalicyclic Acid in Preventing Colorectal Cancer in Patients at High Risk of Colorectal Cancer
Phase 1
Completed
- Conditions
- Colorectal Cancer
- First Posted Date
- 2006-05-31
- Last Posted Date
- 2009-02-09
- Lead Sponsor
- Stony Brook University
- Target Recruit Count
- 240
- Registration Number
- NCT00331786
- Locations
- 🇺🇸
Stony Brook University Cancer Center, Stony Brook, New York, United States
Phase II High-Dose Cyclophosphamide for Multiple Sclerosis
Phase 2
Withdrawn
- Conditions
- Multiple Sclerosis
- First Posted Date
- 2006-02-24
- Last Posted Date
- 2009-07-22
- Lead Sponsor
- Stony Brook University
- Target Recruit Count
- 25
- Registration Number
- NCT00296205
- Locations
- 🇺🇸
Stony Brook University Hospital, Stony Brook, New York, United States
© Copyright 2025. All Rights Reserved by MedPath